Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Lowered to $75 at RBC Capital

February 8, 2017 7:23 AM
RBC Capital lowered its price target on Gilead Sciences (NASDAQ: GILD) to $75.00 (from $90.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles